Search Results - Colin R Lindsay
- Showing 1 - 3 results of 3
-
1
-
2
Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell ca... by Loic Verlingue, Antoine Italiano, Hans Prenen, Eva Maria Guerra Alia, Diego Tosi, Ruth Perets, Iwona Lugowska, Vladimir Moiseyenko, Mahmut Gumus, Cagatay Arslan, Colin R. Lindsay, Sanjeev Deva, Álvaro Taus, Ana Oaknin, Sylvie Rottey, Irfan Cicin, Sema Sezgin Goksu, Alexey Smolin, Susana Roselló-Keränen, Christin Habigt, Daniel Marbach, Christophe Boetsch, David Dejardin, Nassim Sleiman, Stefan Evers, Muriel Richard, Caroline Ardeshir, Jehad Charo, Anton Kraxner, Volker Teichgräber, Nino Keshelava, Rafal Dziadziuszko
Published in EBioMedicine (2024-11-01)Get full text
Article -
3
Should Radiation Dose Be Personalized in Patients With Localized NSCLC and Actionable Genetic Alterations? Insight From a Multicenter Real-World Study by Salman Ashraf, MB BCh BAO, Madeha Khan, FRCR, Nada Naguib, FRCR, Robert Rulach, FRCR, PhD, Katharine Welsh, FRCR, Rebecca Carozzi, MRCP, Ashley Horne, FRCR, Amelia Payne, MRCP, MRes, Sarah Bowen Jones, FRCR, Mary Denholm, FRCR, Georgia Stewart, MB MSc, Ahmed Bedair, FRCR, Colin R. Lindsay, MRCP, PhD, Stephen Harrow, FRCR, PhD, Corinne Faivre-Finn, FRCR, PhD, Jonathan McAleese, FRCR, Gerard G. Hanna, FRCR, PhD, Allan Hackshaw, PhD, Fiona McDonald, FRCR, MD, Gerard M. Walls, FRCR, PhD
Published in JTO Clinical and Research Reports (2025-04-01)Get full text
Article
